Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Ed. by Bancalari, Eduardo / Chappelle, Joseph / Chervenak, Frank A. / D'Addario , Vincenzo / Genc, Mehmet R. / Greenough, Anne / Grunebaum, Amos / Konje, Justin C. / Kurjak M.D., Asim / Romero, Roberto / Zalud, MD PhD, Ivica


IMPACT FACTOR 2018: 1.361
5-year IMPACT FACTOR: 1.578

CiteScore 2018: 1.29

SCImago Journal Rank (SJR) 2018: 0.522
Source Normalized Impact per Paper (SNIP) 2018: 0.602

Online
ISSN
1619-3997
See all formats and pricing
More options …
Volume 47, Issue 7

Issues

Antenatal ultrasound compared to MRI evaluation of fetal myelomeningocele: a prenatal and postnatal evaluation

Jessian L. Munoz / Elaine Bishop / Mitchell Reider / Milena Radeva / Katherine Singh
Published Online: 2019-09-04 | DOI: https://doi.org/10.1515/jpm-2019-0177

Abstract

Background

Spina bifida affects 0.5–1 in 1000 pregnancies in the United States and is often diagnosed in the mid-second trimester. The objective of the study was to directly compare ultrasounds (US) and magnetic resonance imaging (MRI) obtained in the antenatal period in the diagnosis and localization of fetal myelomeningocele (MMC) and compare these with the postnatal outcomes of these infants

Methods

A retrospective analysis of patients referred to the Fetal Care Center at the Cleveland Clinic from 2005 to 2017. US and MRIs were obtained from the Cleveland Clinic electronic medical record. Infants were followed-up at an interdisciplinary myelomeningocele pediatrics clinic.

Results

MRI and US varied in correlation with physical exam at the time of birth and surgery. While no differences were detected in demographics, pregnancy outcomes or pediatric outcomes, it was noted that the majority of patients developed neurogenic bladders irrespective of the lesion level.

Conclusion

MRI is not superior to US in the diagnosis of MMC. Pregnancies complicated by MMC do not vary in morbidity, and pediatric outcomes remain similar regardless of the lesion level. This data provides additional information for the counseling of patients when faced with this antenatal diagnosis.

Keywords: fetal MRI; fetal therapy; myelomeningocele; ultrasound

References

  • 1.

    Blencowe H, Kancherla V, Moorthie S, Darlison MW, ModellB. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci 2018;1414:31–46.CrossrefWeb of SciencePubMedGoogle Scholar

  • 2.

    Borgstedt-Bakke JH, Fenger-Gron M, Rasmussen MM. Correlation of mortality with lesion level in patients with myelomeningocele: a population-based study. J Neurosurg Pediatr 2017;19:227–31.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 3.

    Wilson RD, SOGC Genetics Committee, Special Contributor. Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects. J Obstet Gynaecol Can 2014;36:927–39.PubMedCrossrefGoogle Scholar

  • 4.

    Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina bifida. Nat Rev Dis Primers 2015;1:15007.PubMedCrossrefGoogle Scholar

  • 5.

    Carreras E, Maroto A, Illescas T, Melendez M, Arevalo S, Peiro JL, et al. Prenatal ultrasound evaluation of segmental level of neurological lesion in fetuses with myelomeningocele: development of a new technique. Ultrasound Obstet Gynecol 2016;47:162–7.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 6.

    Trigubo D, Negri M, Salvatico RM, Leguizamon G. The role of intrauterine magnetic resonance in the management of myelomenigocele. Childs Nerv Syst 2017;33:1107–11.Web of SciencePubMedCrossrefGoogle Scholar

  • 7.

    Appasamy M, Roberts D, Pilling D, Buxton N. Antenatal ultrasound and magnetic resonance imaging in localizing the level of lesion in spina bifida and correlation with postnatal outcome. Ultrasound Obstet Gynecol 2006;27:530–6.CrossrefPubMedGoogle Scholar

About the article

Corresponding author: Jessian L. Munoz, MD, PhD, OB/GYN and Women’s Health Institute A81, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA, Tel.: +(216)-210-0756


Received: 2018-11-01

Accepted: 2019-06-28

Published Online: 2019-09-04

Published in Print: 2019-09-25


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Journal of Perinatal Medicine, Volume 47, Issue 7, Pages 771–774, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/jpm-2019-0177.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in